Literature DB >> 25453873

Identification of transcription factors involved in the transcriptional regulation of the CXCL12 gene in rat pancreatic insulinoma Rin-5F cell line.

Jelena Marković1, Aleksandra Uskoković, Nevena Grdović, Svetlana Dinić, Mirjana Mihailović, Jelena Arambašić Jovanović, Goran Poznanović, Melita Vidaković.   

Abstract

Diabetes is characterized by a deficit in the number of functional pancreatic β-cells. Understanding the mechanisms that stimulate neogenesis of β-cells should contribute to improved maintenance of β-cell mass. Chemokine CXCL12 has recently become established as a novel β-cell growth factor, however the mechanisms controlling its expression require clarification. We investigated the proteins involved in the transcriptional regulation of the rat β-cell CXCL12 gene (Cxcl12). Using the electrophoretic mobility shift assay and chromatin immunoprecipitation, we established the in vitro and in vivo binding of C/EBPβ, C/EBPα, STAT3, p53, FOXO3a, and HMG I/Y to the Cxcl12 promoter. Co-immunoprecipitation experiments revealed protein-protein interactions between YY1 and PARP-1, FOXO3a and PARP-1, Sp1 and PARP-1, p53 and PARP-1, C/EBPβ and PARP-1, YY1 and p53, YY1 and FOXO3a, p53 and FOXO3a, Sp1 and FOXO3a, C/EBPβ and FOXO3a, C/EBPα and FOXO3a, Sp1 and STAT3. Our data lay the foundation for research into the interplay of signaling pathways that determine the β-cell Cxcl12 expression profile.

Entities:  

Keywords:  CXCL12; CXCL12 gene promoter; interaction facteur de transcription-promoteur; interaction protéine–protéine; promoteur du gène de CXCL12; protein–protein interaction; régulation transcriptionnelle; transcription factor-promoter interaction; transcriptional regulation

Mesh:

Substances:

Year:  2014        PMID: 25453873     DOI: 10.1139/bcb-2014-0104

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

1.  Caloric restriction and the adipokine leptin alter the SDF-1 signaling axis in bone marrow and in bone marrow derived mesenchymal stem cells.

Authors:  Sudharsan Periyasamy-Thandavan; Samuel Herberg; Phonepasong Arounleut; Sunil Upadhyay; Amy Dukes; Colleen Davis; Maribeth Johnson; Meghan McGee-Lawrence; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Mol Cell Endocrinol       Date:  2015-03-14       Impact factor: 4.102

2.  Mesenchymal stromal cells expressing a dominant-negative high mobility group A1 transgene exhibit improved function during sepsis.

Authors:  Min-Young Kwon; Sailaja Ghanta; Julie Ng; Ana P Castano; Junwen Han; Bonna Ith; James A Lederer; Souheil El-Chemaly; Su Wol Chung; Xiaoli Liu; Mark A Perrella
Journal:  J Leukoc Biol       Date:  2021-01-13       Impact factor: 4.962

3.  Histone deacetylase inhibition protects hearing against acute ototoxicity by activating the Nf-κB pathway.

Authors:  W S Layman; D M Williams; J A Dearman; M A Sauceda; J Zuo
Journal:  Cell Death Discov       Date:  2015

4.  The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.

Authors:  Lingyan Ping; Ning Ding; Yunfei Shi; Lixia Feng; Jiao Li; Yalu Liu; Yufu Lin; Cunzhen Shi; Xing Wang; Zhengying Pan; Yuqin Song; Jun Zhu
Journal:  Oncotarget       Date:  2017-06-13

5.  Basal p53 expression is indispensable for mesenchymal stem cell integrity.

Authors:  Siddaraju V Boregowda; Veena Krishnappa; Jacqueline Strivelli; Christopher L Haga; Cori N Booker; Donald G Phinney
Journal:  Cell Death Differ       Date:  2018-01-08       Impact factor: 15.828

6.  Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma.

Authors:  Dimitra Kerdidani; Panagiotis Chouvardas; Ares Rocanin Arjo; Ioanna Giopanou; Giannoula Ntaliarda; Yu Amanda Guo; Mary Tsikitis; Georgios Kazamias; Konstantinos Potaris; Georgios T Stathopoulos; Spyros Zakynthinos; Ioannis Kalomenidis; Vassili Soumelis; George Kollias; Maria Tsoumakidou
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

Review 7.  The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation.

Authors:  Melita Vidaković; Nevena Grdović; Svetlana Dinić; Mirjana Mihailović; Aleksandra Uskoković; Jelena Arambašić Jovanović
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.